A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease
Clinical trial NCT00954590 · TERMINATED
Trial details
- NCT number
- NCT00954590
- Sponsor
- Medivation, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2010-08-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.